Double Wood wins this category not because TUDCA is a proven liver miracle — it isn't, at least not as an over-the-counter supplement — but because if you're going to take TUDCA anyway, this is the version whose identity and potency are actually checked against a USP standard by HPLC. Each capsule is 250mg, and the labeled 2-capsule serving delivers 500mg, the top of the 250-500mg range used in the pharma and pilot literature. The bitterness people complain about is, ironically, a feature: genuine bile acid tastes foul, which is a rough tell against adulteration. What you're buying is verification and dose flexibility, not a clinical outcome.
Check on AmazonAffiliate link — Super Achiever Club earns a small commission at no extra cost to you.
Read the complete TUDCA guide →Synthesized (not bear-bile) TUDCA, HPLC-verified for identity and potency against a USP reference standard — the single most important thing you can check on a bile-acid supplement, and most brands don't publish it.
Third-party HPLC potency plus heavy-metals and microbial screening. Not the absolute most exhaustive program in the field (BodyBio edges it), but the identity verification against USP is exactly the right test for TUDCA.
250mg/cap scales to a 500mg/day serving — the upper end of the 250-500mg range seen in cholestasis pilot work. You can also run 250mg/day for a gentler, cheaper trial.
TUDCA is generally well tolerated at these doses; the main complaint is bitter aftertaste and occasional loose stools as bile flow shifts. No serious OTC safety signals at 250-500mg.
~$0.50/cap, ~$1.00 per 500mg serving. Not the cheapest, but the cheapest that also gives you HPLC verification — the value case is testing-per-dollar, not raw price.
“Active TUDCA content is HPLC-verified against USP standards for potency and identity.”
Listed certifications confirm third-party HPLC testing versus a USP reference standard, which is the appropriate identity/potency method for a bile acid.
“500mg/day supports liver and bile-flow health.”
500mg sits at the top of the 250-500mg range used in cholestasis literature, and UDCA/TUDCA are established in pharma cholestasis care (PMID 16741551), but rigorous human outcome trials for OTC TUDCA supplementation in healthy livers are lacking.
“The strong bitter taste indicates a genuine, unadulterated bile acid.”
Bile acids are intensely bitter, so bitterness is consistent with real TUDCA, but taste is a heuristic — the HPLC assay, not the flavor, is the actual proof of identity.
TUDCA's OTC market is full of unverified powder. Double Wood publishing HPLC identity/potency against USP is the differentiator — you're paying for the certainty that the capsule contains what the label says, at the dose it says.
Two caps = 500mg, the upper bound of the 250-500mg range in the cholestasis pilot literature (e.g., PMID 9146781). One cap gives a 250mg entry dose. That flexibility from a single SKU is unusual and useful.
Double Wood earns #1 by doing the one thing that matters for a bile-acid supplement: proving, by HPLC against a USP standard, that the powder is real and correctly dosed. Pair that with a clean scale to 500mg/day and a fair price, and it's the pick for anyone who's decided to run TUDCA. Keep expectations calibrated — the evidence supports the mechanism and pharma use, not a guaranteed OTC benefit.
Check Double Wood Supplements on AmazonEstablishes the anticholestatic, cytoprotective and anti-apoptotic mechanisms of UDCA/TUDCA that underpin their pharma use in cholestatic liver disease.
Pilot crossover showing TUDCA and UDCA both improve liver biochemistry in PBC, supporting the 500mg-range dosing used here.
